Similar articles

• Understanding cost-effectiveness.

  Zilberberg MD, Shorr AF. Zilberberg MD, et al. Clin Microbiol Infect. 2010 Dec;16(12):1707-12. doi: 10.1111/j.1469-0691.2010.03331.x. Clin Microbiol Infect. 2010. PMID: 20673258 Review.
• The economics of heart failure.

  Kazi DS, Mark DB. Kazi DS, et al. Heart Fail Clin. 2013 Jan;9(1):93-106. doi: 10.1016/j.hfc.2012.09.005. Heart Fail Clin. 2013. PMID: 23168320 Review. No abstract available.
• The role of costs in comparative effectiveness research.

  Garber AM, Sox HC. Garber AM, et al. Health Aff (Millwood). 2010 Oct;29(10):1805-11. doi: 10.1377/hlthaff.2010.0647. Health Aff (Millwood). 2010. PMID: 20921479
• US healthcare reform: implications for health economics and outcomes research.

  Chambers JD, Neumann PJ. Chambers JD, et al. Expert Rev Pharmacoecon Outcomes Res. 2010 Jun;10(3):215-6. doi: 10.1586/erp.10.32. Expert Rev Pharmacoecon Outcomes Res. 2010. PMID: 20545583 No abstract available.
• Use of comparative effectiveness research in drug coverage and pricing decisions: a six-country comparison.

  Sorenson C. Sorenson C. Issue Brief (Commonw Fund). 2010 Jul;91:1-14. Issue Brief (Commonw Fund). 2010. PMID: 20614655